Use of 2,4-pyrimidinediamines for the treatment of atherosclerosis
US8530466B2 · kind B2 · utility
9Cited by
1References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 20, 2009 |
| Grant date | Sep 10, 2013 |
| Priority date | — |
| Expiry date | Jul 21, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel methods and compositions for the prevention and treatment of all forms of atherosclerosis with 2,4-pyrimidinediamine compounds are described. Also disclosed is the coating of prosthetic devices, such as stents, with the compounds of the invention for the prevention and/or treatment of restenosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.